Estimation of self-funded human papillomavirus vaccine recipients from Japan's previously assumed “unvaccinated generation”

IF 4.5 2区 医学 Q1 ONCOLOGY
Cancer Science Pub Date : 2024-07-11 DOI:10.1111/cas.16272
Mariya Kobayashi, Satoshi Nakagawa, Yutaka Ueda, Asami Yagi, Mamoru Kakuda, Kosuke Hiramatsu, Tadashi Kimura
{"title":"Estimation of self-funded human papillomavirus vaccine recipients from Japan's previously assumed “unvaccinated generation”","authors":"Mariya Kobayashi,&nbsp;Satoshi Nakagawa,&nbsp;Yutaka Ueda,&nbsp;Asami Yagi,&nbsp;Mamoru Kakuda,&nbsp;Kosuke Hiramatsu,&nbsp;Tadashi Kimura","doi":"10.1111/cas.16272","DOIUrl":null,"url":null,"abstract":"<p>Precise vaccination data is essential to accurately estimate the effectiveness of the human papillomavirus (HPV) vaccine against HPV-related cancers. In Japan, the number of subsidized HPV vaccinations can be tracked through registries, but the number of self-funded vaccinations has not been tracked. The number of individuals who chose to receive the vaccine at their own expense, despite being ineligible for public subsidies due to their age, is unknown and has been nominally considered to be zero. Our aim is to produce a more accurate estimate of this number using recently released proprietary data. First, we estimated the total number of self-funded HPV vaccinations occurring from 2010 to 2012 using public data from the Ministry of Health, Labour and Welfare and our previously reported data on the number of HPV vaccinations eligible for public subsidy. Second, using proprietary data from the vaccine manufacturer, we calculated the distribution of self-funded vaccination shots by age. Finally, we combined these data to estimate the number of self-funded HPV vaccinations by birth fiscal year (FY) relative to a yearly reference population. We found that 78,264 individuals born in FY1993 and 58,190 born in FY1992 self-funded their vaccinations, representing 13.6% and 10.0% of the reference population, respectively. Additionally, we found that 5%–10% of individuals born from FY1986 to FY1991 self-funded their vaccinations. Our study revealed for the first time that a certain number of individuals from the “HPV unvaccinated generation,” ineligible for subsidies due to age restrictions, chose to self-fund their vaccinations.</p>","PeriodicalId":9580,"journal":{"name":"Cancer Science","volume":"115 9","pages":"3099-3106"},"PeriodicalIF":4.5000,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cas.16272","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cas.16272","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Precise vaccination data is essential to accurately estimate the effectiveness of the human papillomavirus (HPV) vaccine against HPV-related cancers. In Japan, the number of subsidized HPV vaccinations can be tracked through registries, but the number of self-funded vaccinations has not been tracked. The number of individuals who chose to receive the vaccine at their own expense, despite being ineligible for public subsidies due to their age, is unknown and has been nominally considered to be zero. Our aim is to produce a more accurate estimate of this number using recently released proprietary data. First, we estimated the total number of self-funded HPV vaccinations occurring from 2010 to 2012 using public data from the Ministry of Health, Labour and Welfare and our previously reported data on the number of HPV vaccinations eligible for public subsidy. Second, using proprietary data from the vaccine manufacturer, we calculated the distribution of self-funded vaccination shots by age. Finally, we combined these data to estimate the number of self-funded HPV vaccinations by birth fiscal year (FY) relative to a yearly reference population. We found that 78,264 individuals born in FY1993 and 58,190 born in FY1992 self-funded their vaccinations, representing 13.6% and 10.0% of the reference population, respectively. Additionally, we found that 5%–10% of individuals born from FY1986 to FY1991 self-funded their vaccinations. Our study revealed for the first time that a certain number of individuals from the “HPV unvaccinated generation,” ineligible for subsidies due to age restrictions, chose to self-fund their vaccinations.

Abstract Image

从日本先前假定的 "未接种疫苗的一代 "中估算自费接种人类乳头瘤病毒疫苗的人数。
精确的疫苗接种数据对于准确评估人类乳头瘤病毒 (HPV) 疫苗预防 HPV 相关癌症的效果至关重要。在日本,受资助的 HPV 疫苗接种数量可以通过登记册进行跟踪,但自费接种的数量却没有跟踪。尽管由于年龄原因没有资格获得公共补贴,但选择自费接种疫苗的人数不详,名义上一直被认为是零。我们的目的是利用最近公布的专有数据对这一数字做出更准确的估计。首先,我们利用厚生劳动省的公开数据和之前报告的有资格获得公共补贴的 HPV 疫苗接种数据,估算了 2010 年至 2012 年期间自费接种 HPV 疫苗的总数。其次,我们利用疫苗生产商提供的专有数据,按年龄计算了自费疫苗接种的分布情况。最后,我们将这些数据结合起来,估算出相对于每年的参考人群,按出生财政年度(FY)划分的自费 HPV 疫苗接种数量。我们发现,1993 财政年度出生的 78,264 人和 1992 财政年度出生的 58,190 人自费接种了疫苗,分别占参考人群的 13.6% 和 10.0%。此外,我们还发现 5%-10%的 1986 至 1991 财政年度出生的人自费接种疫苗。我们的研究首次发现,由于年龄限制而没有资格获得补贴的 "未接种 HPV 的一代 "中,有一定数量的人选择自费接种疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Science
Cancer Science 医学-肿瘤学
自引率
3.50%
发文量
406
审稿时长
2 months
期刊介绍: Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports. Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信